Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Carboplatin in Advanced Collecting Duct Renal Cell Cancer
NCT00077129Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Jun 2006
- Primary completion
- Aug 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, carboplatin in collecting duct renal cell carcinoma (CDRCC), sponsored by Eastern Cooperative Oncology Group. Started Jun 2006; status: completed.
02
Drugs
paclitaxelcarboplatin
03
Conditions
collecting duct renal cell carcinoma (CDRCC)
Beyond the preview
Go deeper on NCT00077129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077129.